Showing results (541-550 of 553) with videos related to

Sort By:
Pageof 56
Drugs in Context|May 19, 2025
Patterns of treatment and outcomes of patients with metastatic HER2-low breast cancer treated with CDK4/6 inhibitors and hormone therapyFederico Sottotetti, Barbara Tagliaferri, Gianpiero Rizzo, et al.
Drugs in Context|March 13, 2025
Vericiguat in patients with heart failure and implantable cardioverter-defibrillatorCarlos Escobar, Jesús Saldaña, José Luis Merino, et al.
Drugs in Context|February 28, 2025
Real-life effectiveness of FLOT in resectable gastric cancer: existing challengesFrancesco Serra, Federica Valerio, Paolo Pedrazzoli, et al.
Drugs in Context|June 20, 2024
Corrigendum: Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences
Drugs in Context|May 31, 2024
Feasibility and reliability of a quality indicator system for an ambulatory dispensing serviceAndrea Jetzú Bautista Gómez, Maricela López Orozco, Liliana Barajas Esparza, et al.
Drugs in Context|May 21, 2024
Real-world prevalence of integrase inhibitor resistance and virological failure since adoption as guideline-preferred therapyJenna Januszka, Emily Drwiega, Rodrigo Burgos, et al.
Drugs in Context|December 22, 2025
Adjuvant abemaciclib in early-stage breast cancer: hypothesis-generating safety observations from a real-world cohort studyFederico Sottotetti, Simone Figini, Giulia Gambini, et al.
Drugs in Context|May 3, 2024
Understanding treatment goals and their application in clinical trial design for patients with Alzheimer disease and caregiversDavid Gómez-Ulloa, M Chris Runken, Wilton I Rodriguez, et al.
Drugs in Context|December 27, 2023
Fentanyl in cancer pain management: avoiding hasty judgments and discerning its potential benefitsArturo Cuomo
Drugs in Context|June 29, 2026
Primary Sjögren's syndrome-associated interstitial lung disease: a case report with favourable response to tocilizumabNegar Naseri, Nadia Jalili, Farzad Rafiei, et al.
Pageof 56